Cite
HARVARD Citation
Muro, K. et al. (n.d.). Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial. Lancet oncology. 17 (6), pp. 717-726. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Muro, K. et al. (n.d.). Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial. Lancet oncology. 17 (6), pp. 717-726. [Online].